GENOM BIO

Synergizing Development | Miaoshun Bio and GENOMBIO Explore New Pathways for Biopharmaceutical Collaboration

2025-08-06 15:57 Source: admin Clicks: 33

图片1.png

图片2.png

On the afternoon of June 19, 2025, a delegation of five led by Zuo Zhimin, Product Director of Miaoshun (Shanghai) Biotechnology Co., Ltd., visited the Genom Life Health Industrial Park in Lixin Economic Development Zone, Bozhou, Anhui Province. The visit aimed to deepen mutual understanding and explore synergistic opportunities in the biopharmaceutical field.


Deepening Understanding: From Industrial Layout to Core Products & Services

图片3.png

At the GENOMBIO exhibition hall, the delegation received a systematic introduction to the Group’s profile, 23-year development journey, industrial footprint, and core products/services. As a national high-tech enterprise pioneering in biopharmaceuticals, GENOMBIO has dedicated itself to the full-cell industry chain, spanning cell culture reagents/consumables, cell banking, cell therapy drug R&D, stem cell exosome applications, technical services, and organoid products/services. Key products include fetal bovine serum, Matrigel, serum-free media series, organoid culture media series, "LungShuKang," and "Jiuxiao Yunwai." The exhibition highlighted Genom Life Bank, cell testing, cell preparation, cell therapy, cell products, and its integrated health project and medical service network, showcasing comprehensive capabilities in cell technology R&D and industrialization.

图片4.png


On-Site Inspection: Focusing on Production and Quality Control

图片5.png

Accompanied by Guo Yonglin, Vice President of GENOMBIO, Director Zuo’s team toured Workshop 3, the R&D Center, Quality Center, and warehouse facilities. VP Guo detailed production capacity, core equipment, key process designs, and stringent quality control systems. During the inspection, both parties engaged in in-depth discussions on GENOMBIO’s development strategy, management philosophy, corporate culture, and talent cultivation.

图片6.png


Future Collaboration Prospects: Establishing Long-Term Cooperation Mechanisms

图片7.png

At the collaboration forum, Miaoshun Bio and GENOMBIO reached multiple agreements:

  • Establishing regular communication and technical mechanisms to ensure efficient progress through structured exchanges.

  • Committing to optimize collaboration models, maintain close coordination, and promptly address challenges.
    Both enterprises pledged to build a stable, mutually trusting, and win-win strategic partnership, laying a solid foundation for long-term cooperation through enhanced process management and resource integration, thereby elevating industrial synergy to new heights.